5-HT2A/5-HT2C inverse agonist 1

• UNSPSC Description:

  5-HT2A/5-HT2C inverse agonist 1 is a potent and dual 5-HT2A and 5-HT2C receptor inverse agonist with a hERG inhibitions, thus avoiding cardiovascular risks. 5-HT2A/5-HT2C inverse agonist 1 shows significant antipsychotic efficacy in the MK-801 (HY-15084B)-induced mouse model. 5-HT2A/5-HT2C inverse agonist 1 is promising for research of psychosis[1].

• Target Antigen:

  5-HT Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/5-ht2a-5-ht2c-inverse-agonist-1.html

• Smiles:

  CN(C=C1)N=C1CN([C@@H]2C3(CN(CC2)C)CC3)C(NCC4=CC=C(C=C4)OCCC)=O

• Molecular Weight:

  425.57

• References & Citations:

  [1]Oguma T, et al. Dual 5-HT2A and 5-HT2C Receptor Inverse Agonist That Affords In Vivo Antipsychotic Efficacy with Minimal hERG Inhibition for the Treatment of Dementia-Related Psychosis. J Med Chem. 2024 Aug 22;67(16):14478-14492.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2718990-76-0